1316189-13-5 mPEG8-NHS
137854-42-3 3-Furancarboxylic acid,5-(5-methoxy-3-methyl-5-oxo-1,3-pentadienyl)-2-phenyl-, ethyl ester,(E,E)-
137854-48-9 2,4-Pentadienoic acid,5-(4-acetyl-1,5-dimethyl-1H-pyrrol-2-yl)-3-methyl-, methyl ester, (E,E)-
29189-45-5 Iron,chloro[5,10,15,20-tetraphenyl-21H,23H-porphinato(2-)-kN21,kN22,kN23,kN24]-, (SP-5-12)-
63966-50-7 1,4-Benzenediol, 2-(octadecylamino)-, 1-benzoate
61759-69-1 Carbamothioic acid, ethyl-, S-(3,7-dimethyl-2,6-octadienyl) ester
628703-52-6 Isoquinoline, 1-[(aminooxy)methyl]-
2925-37-3 pentanoic acid, 3-fluoropropyl ester
29272-94-4 Ethanone, 2-(acetyloxy)-1-(4-octylphenyl)-
848697-35-8 3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine,7-chloro-3-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-
35811-56-4 Ethanone, 1-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-
316363-65-2 Lurasidone Impurity 2
316374-99-9 acrylate, 1,1'-methylenebis[4-isocyanatobenzene],
31638-34-3 2-(2-AMINOMETHYLPHENYL)BENZOIC ACID
916976-51-7 9H-Purine, 9-ethyl-6-(4H-1,2,4-triazol-4-yl)-
916976-52-8 9H-Purine, 9-butyl-6-(4H-1,2,4-triazol-4-yl)-
Serving Advanced Chemicals to Global Customers
© 2009 - 2025 USCKS | King-Pharm Ver 3.0